ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,53
0,23%
Bitcoin
69 555,42
-0,14%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Histogenics Corporation (HSGX)

  7. Histogenics Corporation (HSGX) Actualités

HSGX

Histogenics (HSGX)

Histogenics Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HSGX
DateHeureSourceTitreSymboleSociété
21/11/201913h00GlobeNewswire Inc.Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial OfficerNASDAQ:HSGXHistogenics Corporation
12/11/201922h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HSGXHistogenics Corporation
08/11/201922h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HSGXHistogenics Corporation
08/11/201913h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HSGXHistogenics Corporation
06/11/201914h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:HSGXHistogenics Corporation
06/11/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:HSGXHistogenics Corporation
28/10/201921h59Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:HSGXHistogenics Corporation
15/10/201921h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HSGXHistogenics Corporation
07/10/201923h31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HSGXHistogenics Corporation
07/10/201923h29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:HSGXHistogenics Corporation
07/10/201919h32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HSGXHistogenics Corporation
04/10/201918h56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HSGXHistogenics Corporation
02/10/201914h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HSGXHistogenics Corporation
26/09/201923h12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HSGXHistogenics Corporation
26/09/201922h25GlobeNewswire Inc.Histogenics Corporation Announces Approval of Merger by Stockholders at Special MeetingNASDAQ:HSGXHistogenics Corporation
12/09/201915h15GlobeNewswire Inc.Histogenics Corporation Announces Adjournment of its Special Meeting to Thursday, September 26, 2019NASDAQ:HSGXHistogenics Corporation
11/09/201922h05GlobeNewswire Inc.Histogenics Corporation Announces Intent to Convene and Adjourn Its Special MeetingNASDAQ:HSGXHistogenics Corporation
02/08/201919h13Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:HSGXHistogenics Corporation
27/06/201922h32Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:HSGXHistogenics Corporation
14/06/201923h24Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:HSGXHistogenics Corporation
08/04/201913h00GlobeNewswire Inc.Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel...NASDAQ:HSGXHistogenics Corporation
22/03/201911h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HSGXHistogenics Corporation
14/02/201923h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HSGXHistogenics Corporation
12/02/201914h00GlobeNewswire Inc.Jonathan Lieber Joins Danforth Advisors as Managing DirectorNASDAQ:HSGXHistogenics Corporation
21/12/201822h05GlobeNewswire Inc.Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory PathwayNASDAQ:HSGXHistogenics Corporation
29/11/201814h30GlobeNewswire Inc.Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory PathwayNASDAQ:HSGXHistogenics Corporation
08/11/201812h30GlobeNewswire Inc.Histogenics Corporation Announces Third Quarter 2018 Financial and Operating ResultsNASDAQ:HSGXHistogenics Corporation
01/11/201821h05GlobeNewswire Inc.Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory PathwayNASDAQ:HSGXHistogenics Corporation
25/10/201822h15GlobeNewswire Inc.Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018NASDAQ:HSGXHistogenics Corporation
18/10/201822h48Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HSGXHistogenics Corporation
 Showing the most relevant articles for your search:NASDAQ:HSGX

Dernières Valeurs Consultées

EU
J272S
J272S
ASX
FAS
Fairstar Resources
BOV
PETRT400
PETRT400 Ex:20,2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés